Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
Alternative names
autologous adipose-derived mesenchymal stem cells (1 trial)
Enuresis (Phase 2)
Urinary Incontinence (Phase 2)
Trials (1 total)
Trial APIs (1 total)